Analysis of Artificial Saliva market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global artificial saliva market revenue totaled US$ 667.9 Mn in 2020. The market is expected to reach a valuation of US$ 1.4 Bn by 2026, surging ahead at a CAGR of 13.3% over the same period.
Artificial Saliva Market Size (2020)
US$ 667.9 Mn
Projected Year Value (2026)
US$ 1.4 Bn
Global Market Growth Rate (2021-2026)
China Market Growth Rate (2021-2026)
Key Companies Profiled
Demand for oral sprays is expected to increase at 14.1% CAGR from 2021 to 2026 because they are very convenient to use and also cost-effective.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
“Rising Awareness Regarding Artificial Saliva Products Aiding Market Growth”
As per Fact.MR, a market research and competitive intelligence provider, the global artificial saliva market was valued at US$ 667.9 Mn in 2020.
Saliva is necessary for the healthy functioning of the oral cavity, and its dilution can result in a variety of disorders. Artificial saliva is a substitute for natural saliva that moistens and lubricates the mouth for a short time. It also aids in the control of germs in the mouth, which aids in the prevention of illness and dental cavities. Artificial saliva can help you avoid health problems by alleviating the symptoms of dry mouth.
Oral health maintenance costs are a significant healthcare concern that has a direct impact on the artificial saliva industry. Because the artificial saliva market is primarily driven by consumers, a rise in per-capita spending and disposable income are expected to boost the industry over the projected period.
The market is predicted to expand as the number of instances of cancer rises, as well as the demand for treatments such as radiation and chemotherapy, which raise the risk of dry mouth. Other aspects driving the artificial saliva market over the forecast period include an ageing population, more awareness about the less adverse effects and complications of oral gels and oral liquids, and increased spending on oral care products.
These factors are expected to drive the worldwide artificial saliva market at a high 13.3% CAGR from 2021 to 2026.
“Growing Prevalence of Dysphagia & Continuous R&D Activities Fuelling Industry Growth”
Rising prevalence of xerostomia, often known as dry mouth syndrome, which causes decreased salivary flow and mucosal dryness, is propelling the artificial saliva industry forward. The increased incidences of cancer around the world are also driving demand for the product, as the odds of dry mouth syndrome and dysphagia increase with radiation therapy and chemotherapy.
Growing senior population, more awareness of the fewer issues connected with oral gels and liquids, and rising per capita expenditure on oral care products all contribute to this trend.
Growing investments in R&D activities to prepare enhanced formulations that can support the function of natural saliva, such as through extended antibacterial action, are likely to positively influence market growth over the projection period.
“Availability of Several Alternatives to Treat Dry Mouth Syndrome Hampering Market Growth”
Several options for treating a dry mouth, including herbal treatments, acupuncture, and salivary stimulants, all of which limit the artificial saliva market growth.
R&D activities in the creation of artificial salivary glands for patients suffering from salivary gland impairment, as well as saliva stimulating pens, are factors hampering demand growth of artificial saliva to some extent.
“Prominent Presence of Innovative Healthcare Solutions to Boost Industry Expansion in North America”
North America is likely to account for a considerable share of the industry due to the easy availability of artificial saliva products, innovative healthcare solutions by market players, and strong consumer spending power in the region.
Favorable compensation scenario and rising initiatives to raise xerostomia awareness are also driving the sales of artificial saliva products in North America.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
“Rising Prevalence of Sjogren’s Syndrome in the United States”
The U.S. artificial saliva market was valued at US$ 228.2 Mn in 2020 and is expected to rise at a significant CAGR over the forecast period.
Growing prevalence of xerostomia & Sjogren’s syndrome and better healthcare infrastructure & facilities are factors boosting market growth in the U.S.
“Growing Product Pipeline for Dry Mouth Treatment Driving Market Revenue”
The market in China is expected to reach a valuation of US$ 249.8 Bn by 2026, representing a 12.8% CAGR from 2021 to 2026.
Oral disorders such as dry mouth are becoming increasingly widespread as the world's population ages. Furthermore, medical professionals, healthcare providers, and dentists are always working to educate clients about the impacts of xerostomia and other dental disorders.
Furthermore, significant research activities, growing product pipeline, and the presence of major players are driving expansion growth in China.
“Oral Sprays Gaining Traction Owing to Their Efficiency & Low Cost”
Oral sprays are expected to hold the largest market share of 35% in 2022. Sales of oral sprays are anticipated to increase at 14.1% CAGR and reach US$ 579.2 Mn by 2026.
Because of their ease of use and user-friendliness, oral sprays are projected to remain a popular choice among customers.
Oral sprays are commonly used to treat dry mouth. Healthcare providers are actively recommending these sprays to reduce drug side effects and hence improve quality of life. Oral sprays are also freely accessible to consumers because they do not require a doctor's prescription and are kept in large quantities by pharmacists or stores.
“Mail Order Pharmacies More Preferred Due to Easy Availability of Artificial Saliva Products”
Mail order pharmacies are expected to hold the highest share of the market during the forecast period. The most frequent treatment for xerostomia is artificial saliva products, which are readily available in pharmacies and on the internet.
Non-adherence to medication, on the other hand, is a key issue that leads to poor outcomes. However, multiple studies have indicated that using mail order pharmacy deliveries improves prescription adherence.
Furthermore, various benefits provided by mail order pharmacies, such as home delivery, health plan discounts, personalized customer service, and easy medicine refilling, are projected to drive the demand for mail order pharmacies over the forecast period.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The COVID-19 pandemic wreaked havoc on the economy and society. Several firms' supply chains and value chains were affected by the pandemic. The market for artificial saliva is no exception. Due to large-scale bans and shutdowns, travel restrictions, and a halt in non-emergency procedures, the global pandemic of COVID-19 harmed artificial saliva product sales growth.
Consumers' purchasing patterns switched to online shopping. As a result, key players are putting more emphasis on boosting their online presence. Market players are also attempting to deliver comprehensive solution ideas to clients, particularly end users, which is assisting artificial saliva industry growth.
As part of their efforts to strengthen their market position, artificial saliva product suppliers are pursuing partnership and joint venture tactics. In order to launch new product versions that will help them enhance their market presence, top artificial saliva product suppliers have been chasing approval bodies such as the FDA or the DCGA.
For instance :
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesBuy Now
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
From 2021 to 2026, demand for artificial saliva is anticipated to surge at a CAGR of 13.3%.
By the end of 2026, the global market for artificial saliva is predicted to reach a valuation of US$ 1.4 Bn.
The U.S., Canada, Japan, China, and Germany are expected to drive most of the demand for artificial saliva products.
Bausch Health Companies Inc., Cipla Ltd., Forward Science, Fresenius Kabi AG, and GlaxoSmithKline PLC are top artificial saliva manufacturers.
The global artificial saliva market was valued at US$ 750 Mn in 2021.
Rising prevalence of dry mouth syndrome and increasing R&D initiatives for related treatments are fueling sales of artificial saliva.
Need An Exclusive Report For Your Unique Requirement?